business news in context, analysis with attitude

Caremark Rx shareholders voted Friday in favor of the $26 billion takeover of the company by retailer CVS, a move that followed by just a day a similar vote by CVS stockholders. The deal is expected to close “quickly,” according to both sides, and end moves by Caremark’s rival, Express Scripts, to beat out the CVS effort.

The deal will merge one of the nation’s largest drugstore chains with the largest pharmacy-benefits manager, creating a major player in the health-care industry, with significant buying power in generic drugs and dominant positions in numbers of retail outlets and mail-order capability. The combined companies are expected to fill or manage as many as one billion prescriptions a year.
KC's View: